Skip to content
Use caution Drug recall · FDA · Published October 20, 2026

Hikma Recalls Ciprofloxacin 750mg Due to Impurity

Hikma recalls 20,335 bottles of Ciprofloxacin 750mg tablets due to N-nitroso-ciprofloxacin impurities exceeding FDA limits. Check your lot numbers.

🇺🇸 FDA recall #D-0166-2027DrugHikma Pharmaceuticals ›
✎ GovInfoNow plain-language explainer

Hikma Pharmaceuticals USA Inc. is recalling 20,335 bottles of Ciprofloxacin Tablets, USP, 750 mg because they contain N-nitroso-ciprofloxacin above the FDA's recommended interim control limit. This impurity can form during manufacturing if Good Current Manufacturing Practices (CGMP) are not followed. The recall covers specific lots distributed nationwide. Read more at govinfonow.com/recall/2249335-hikma-pharmaceuticals-usa-inc-recalls-ciprofloxacin-tablets-usp-750-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/2249335-hikma-pharmaceuticals-usa-inc-recalls-ciprofloxacin-tablets-usp-750-mg · Published November 17, 2026 · Updated November 17, 2026 · FDA enforcement record: FDA #D-0166-2027

Cite this page

“Hikma Recalls Ciprofloxacin 750mg Due to Impurity.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2249335-hikma-pharmaceuticals-usa-inc-recalls-ciprofloxacin-tablets-usp-750-mg. Based on FDA recall #D-0166-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0166-2027%22&limit=1).

The FDA announced on Oct. 20, 2026, that Hikma Pharmaceuticals USA Inc. voluntarily recalled Ciprofloxacin Tablets, USP, 750 mg due to CGMP deviations resulting in N-nitroso-ciprofloxacin levels exceeding the agency's recommended interim control limit.

How to tell if you have it

  • Brand: Hikma Pharmaceuticals
  • Product: Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle
  • NDC: 0143-9929-50
  • Lot codes: CA083A, CA084A, CA085A
  • Expiration dates: 12/31/2026
  • Quantity: 20,335 bottles
  • Distribution: US Nationwide

The hazard

According to the FDA, the recall addresses CGMP deviations where N-nitroso-ciprofloxacin results were found above the FDA recommended interim control limit.

Context

GovInfoNow's records show Hikma Pharmaceuticals USA Inc. has 16 other recalls on record since Dec. 17, 2019. Other recent recalls of similar products include Abirtega Tablets (Oct. 6, 2026), Ramipril Capsules (Aug. 24, 2026), and Alendronate Sodium Oral Solution (April 7, 2026). Other recent recalls of similar products include Fosfomycin Tromethamine Granules (Sept. 18, 2026), Furosemide 80mg (March 20, 2026), and Prazosin Capsules (March 27, 2026).

How to tell if you have this one

Check your bottle for NDC 0143-9929-50 and look for one of the following lot numbers: CA083A, CA084A, or CA085A. Verify that the expiration date is 12/31/2026. The product is a 50-count bottle of Rx-only tablets.

  • Brand
    Hikma Pharmaceuticals
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US Nationwide
Recall numberProduct, codes & lotsQuantity
D-0165-2027Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01; Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/202629,085 bottles
D-0166-2027Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50; Lot# CA083A Exp. 12/31/2026 Lot# CA084A Exp. 12/31/2026 Lot# CA085A Exp. 12/31/202620,335 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Your Lot Number

    Look at your Ciprofloxacin bottle to see if it matches NDC 0143-9929-50 and has lot number CA083A, CA084A, or CA085A.

  2. Contact Your Pharmacist

    If you have the recalled product, speak with your pharmacist or healthcare provider about replacing it or discontinuing use.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 22 days after the firm started it.

1. Firm started the recall: Oct 20, 202612. FDA classified it Class II: Nov 3, 202623. Published in FDA’s Enforcement Report: Nov 11, 202634. Added to GovInfoNow: Nov 17, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the recalled product?

The National Drug Code (NDC) for the affected product is 0143-9929-50.

How many bottles are being recalled?

A total of 20,335 bottles are included in this recall.

Similar recalls

Other Hikma Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0166-2027 (October 20, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0166-2027 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA